SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Trading Update

1 Feb 2021 07:00

RNS Number : 9708M
James Halstead PLC
01 February 2021
 

 

 

1 February 2021

 

JAMES HALSTEAD PLC(the "Company")

Trading Update

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update ahead of its interim results for the half-year to 31 December 2020.

 

The backdrop to the trading period remained challenging with the resurgence of the Covid-19 virus and subsequent lockdown restrictions across most of the territories in which we trade. Nevertheless, the normal course of business has evolved and we continue to trade at normal levels through the various national lockdowns, but it has been hard work. The cost and availability of international freight towards the end of the period has also been a major issue - and there has been upward pressure on raw material costs.

 

In his AGM statement, on 12 November 2020, the Chairman, Mr. Anthony Wild, noted that trading to date had been encouraging in terms of turnover for the first four months of the current financial year with sales on a par with the levels of last year. This trend continued through November and December. Diverse projects using our flooring include a 10 cinema IMAX complex in Aruba, the AXA Insurance Towers in Casablanca, several modular hospital contracts in Argentina and the Big Brother house in Portugal.

 

Turnover has been solid and we believe this is a creditable performance against the prevailing market conditions. There was noticeable market share growth in the UK in November and December, due in part to "Brexit" concerns of customers about supply from European based competitors. Underlying margins were under pressure due to increased shipping costs both into the UK and on exports plus the difficulties of manufacturing during the six months owing to understandable manning problems. Notwithstanding this adversity, the Company expects to report pre-tax profit for the half-year in line with last year's record level.

 

Our balance sheet remains robust, with cash balances above our year end in June and the comparative for December 2019.

 

The interim results will be published on 31 March 2021.

 

Enquiries:

 

 

 

James Halstead plc

Tel: 0161 767 2500

Mark Halstead, Chief Executive

 

Gordon Oliver, Finance Director

 

 

 

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon /Nick Moore

 

 

 

Panmure Gordon (Nomad and Joint Broker)

Tel: 020 7886 2500

Dominic Morley/ Dan Norman

 

 

 

WH Ireland (Joint Broker)

Ben Thorne / Chris Hardie

 

Tel: 020 7220 1666

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKABKOBKDADB
Date   Source Headline
31st Mar 20237:00 amRNSInterim Results
2nd Feb 20237:00 amRNSTrading Update
1st Dec 20224:36 pmRNSResults of Annual General Meeting
1st Dec 20227:00 amRNSChairman’s Statement to the Annual General Meeting
14th Oct 20225:46 pmRNSPosting of Annual R&A and Notice of AGM
3rd Oct 20227:00 amRNSPreliminary Results
14th Sep 20221:01 pmRNSNotice of Preliminary Results
16th Aug 20223:59 pmRNSPDMR Exercise of Share Options
10th Aug 20224:00 pmRNSPDMR Grant of Share Options
1st Aug 20227:00 amRNSTrading Update
13th Jul 202211:24 amRNSBlock Listing Six Monthly Return
5th May 202210:48 amRNSTR-1: Notification of Major Holdings
31st Mar 20227:00 amRNSInterim Results
1st Feb 20227:00 amRNSTrading Update
17th Jan 202211:00 amRNSTotal Voting Rights and Application for Listing
13th Jan 20222:50 pmRNSApplication for Bonus Shares
7th Jan 20229:36 amRNSBlock Listing Six Monthly Return
7th Jan 20229:32 amRNSTotal Voting Rights
18th Nov 202111:13 amRNSResults of Annual General Meeting
18th Nov 20217:00 amRNSChairman’s Statement to the Annual General Meeting
15th Oct 20214:00 pmRNSPosting of Annual R&A and Notice of AGM
4th Oct 20217:00 amRNSPreliminary Results
20th Sep 20212:46 pmRNSNotice of Preliminary Results
4th Aug 20217:00 amRNSTrading Update
14th Jul 20215:00 pmRNSBlock Listing Six Monthly Return
25th Jun 20214:35 pmRNSPrice Monitoring Extension
22nd Jun 20214:00 pmRNSPDMR Exercise of Share Options
31st Mar 20217:00 amRNSInterim Results
1st Feb 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSBlock Listing Six Monthly Return
12th Nov 202011:00 amRNSResults of Annual General Meeting
12th Nov 20207:00 amRNSChairman's Statement to the Annual General Meeting
16th Oct 20204:00 pmRNSPosting of Annual Report and Notice of AGM
1st Oct 20207:00 amRNSPreliminary Results
24th Sep 20207:00 amRNSNotice of Preliminary Results
7th Sep 202010:12 amRNSTR-1 Notification of Major Holdings
14th Aug 20203:35 pmRNSTR1: Notification of Major Holdings
30th Jul 20207:00 amRNSPre-Close Trading Statement
28th Jul 20204:49 pmRNSBlock Listing Six Monthly Return
5th May 20207:00 amRNSAppointment of Joint Broker
31st Mar 20207:00 amRNSInterim Results
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
23rd Mar 20201:00 pmRNSUpdate from the CEO
20th Mar 202012:08 pmRNSSecond Price Monitoring Extn
20th Mar 202012:03 pmRNSPrice Monitoring Extension
5th Feb 20204:59 pmRNSBlock listing Interim Review
5th Feb 20204:58 pmRNSTotal Voting Rights
30th Jan 20207:00 amRNSTrading Update
6th Dec 20194:35 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.